Effects of ursodeoxycholic acid (UDCA) o
โ
E. Rolandi; R. Franceschini; A. Cataldi; V. Cicchetti; L. Carati; T. Barreca
๐
Article
๐
1991
๐
Springer
๐
English
โ 347 KB
The effects of ursodeoxycholic acid (UDCA, 450 mg daily) in patients with histologically proven chronic active hepatitis (CAH) have been evaluated in a randomized, double-blind, placebo-controlled study. Twenty-six patients with serum alanine aminotransferase (ALT) values at least twice the normal u